Executive Team
Wilson Zhang, M.D., Chief Executive Officer
Business management executive with 20 years’ experience working with diagnostics corporate business development sector, joint venture and international collaboration projects, and M&A activities.
John Christie, MBA, Chief Operating Officer
Business development executive with 20 years’ experience working with biotechnology and developing IP strategy on an international scale.
Bo Ning, Ph.D., Chief Technology Officer
Contributed the key design for CRISPR detection of TB and published a series of papers in leading peer-reviewed journals including Nature Nanotechnology, Lancet Microbe, Science Advances, JCI, Biosensor & Bioelectronics and Cell Reports Methods.
Tony Hu, Ph.D., Chief Science Advisor
Weatherhead Presidential Chair in Biotechnology Innovation
Director, Center for Intelligent Molecular Diagnostics
Professor of Biochemistry and Molecular Biology, Microbiology, and Biomedical Engineering
School of Medicine, Tulane University
Yuanyuan Kang, Ph.D., Research & Development Director
15+ years research in academia and industry. Experienced in the development, qualification, and validation of CLIA, cGMP, and cGLP-qualified molecular biomarker assays for preclinical and clinical trials in phases I, II, and III.